Healthcare · Drug Manufacturers General · NASDAQ
| Market cap | $222.32B |
|---|---|
| Trailing P/E | 18.4 |
| FCF yield | 3.6% |
| Revenue growth (YoY) | +9.9% |
| EPS growth (YoY) | +10.2% |
| FCF/share growth (YoY) | -22.2% |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
Amgen Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| David J. Taylor | House | Buy | $1,001 - $15,000 | Jun 11, 2026 |
| David J. Taylor | House | Sell | $1,001 - $15,000 | Mar 5, 2026 |
| David J. Taylor | House | Buy | $1,001 - $15,000 | Jan 30, 2026 |
| David J. Taylor | House | Sell | $1,001 - $15,000 | Dec 5, 2025 |
| Marjorie Taylor Greene | House | Buy | $1,001 - $15,000 | Oct 27, 2025 |
| Lisa McClain | House | Sell | $1,001 - $15,000 | Oct 1, 2025 |
| Julia Letlow | House | Buy | $1,001 - $15,000 | Aug 11, 2025 |
| Scott Scott Franklin | House | Buy | $1,001 - $15,000 | May 19, 2025 |
| Jared Moskowitz | House | Buy | $1,001 - $15,000 | Apr 30, 2025 |
| Rob Bresnahan | House | Sell | $1,001 - $15,000 | Apr 8, 2025 |
| Jefferson Shreve | House | Buy | $15,001 - $50,000 | Mar 1, 2025 |
| Daniel Meuser | House | Sell | $1,001 - $15,000 | Feb 11, 2025 |